Ratings Corebridge Financial, Inc.

Equities

CRBG

US21871X1090

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
26.75 ^USD	+0.26%		-0.85%	+23.50%

Apr. 26	Corebridge Financial, Inc. Announces Board Changes	CI
Apr. 15	Morgan Stanley Adjusts Corebridge Financial's Price Target to $28 From $26, Keeps Equalweight Rating	MT

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The earnings growth currently anticipated by analysts for the coming years is particularly strong.
The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
COREBRIDGE FINANCIAL, INC.	+23.50%	16.65B	-
AXA	+14.78%	79.51B	B-
METLIFE, INC.	+6.49%	50.92B	B+
AFLAC INCORPORATED	+1.35%	48.11B	B
PRUDENTIAL FINANCIAL, INC.	+6.55%	39.71B	B+
GENERALI	+19.34%	37.78B	B
SUN LIFE FINANCIAL INC.	+2.84%	30.07B	B
GREAT-WEST LIFECO INC.	-7.77%	27.56B	B-
PRUDENTIAL PLC	-18.42%	24.71B	A-
CATHAY FINANCIAL HOLDING CO., LTD.	+6.89%	21.99B	A

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes